Table 4.
Protein C Percentiles |
||||||
---|---|---|---|---|---|---|
<20th | 20th–39th | 40th–59th | 60th–79th | ≥80th | P for trend | |
Range, μg/mL | <2.6 | 2.7–2.9 | 3.0–3.2 | 3.3–3.6 | ≥3.7 | |
No. at risk | 2,705 | 2,650 | 2,899 | 2,871 | 2,754 | |
No. of cases | 233 | 236 | 271 | 238 | 279 | |
Person-years of follow-up | 41,323 | 41,196 | 45,201 | 44,857 | 43,072 | |
Incidence rate/1000 person-years | 5.6 | 5.7 | 6.0 | 5.3 | 6.5 | |
Age-, race-, and sex-adjusted RR (95% CI) | 0.74 (0.62–0.88) | 0.78 (0.65–0.93) | 0.85 (0.72–1.00) | 0.76 (0.64–0.90) | 1.0 | 0.002 |
Multivariate-adjusted* RR (95% CI) | 0.75 (0.63–0.90) | 0.83 (0.69–0.99) | 0.92 (0.77–1.09) | 0.83 (0.70–0.99) | 1.0 | 0.004 |
Multivariate-adjusted† RR (95% CI) | 0.92 (0.76–1.11) | 0.95 (0.80–1.14) | 1.01 (0.85–1.20) | 0.89 (0.74–1.06) | 1.0 | 0.57 |
Adjusted for age, race-field center, sex, systolic blood pressure, use of antihypertensive medication, smoking status, diabetes mellitus, and education.
Further adjustment for LDL cholesterol, HDL cholesterol, fibrinogen, and von Willebrand factor.